Consumer Alert: Guidant Defibrillators Recalled

On Friday, June 17, Guidant announced a recall of the Ventak Prizm 2 and additional model ICD's.

June 20, 2005

According to news reports, several models of Guidant Cardioverter Defibrillators may have flaws that could cause them to short-circuit and malfunction and cause injury or death. Last month, Guidant disclosed that there were electrical problems with its Ventak Prizm 2 Defibrillators, of which approximately 24,000s have been implanted in persons worldwide. On Friday, June 17, Guidant announced a recall of the Ventak Prizm 2 and additional model ICD's. The Guidant recall includes:

  • VENTAK PRIZM 2 DR (Model 1861) ICDs manufactured on or before April 16, 2002.
  • CONTAK RENEWAL (Model H135) and CONTAK RENEWAL 2 (Model H155) CRT-Ds manufactured on or before August 26, 2004.
  • VENTAK PRIZM AVT, VITALITY AVT, RENEWAL 3 AVT and RENEWAL 4 AVT ICDs (All series numbers).

The manufacturer, Guidant Corporation, is headquartered in St. Paul Minnesota.

Guidant Cardioverter Defibrillators (ICD) are implanted devices that detect abnormal heart rhythms (ventricular arrhythmias) and shock the heart back to a normal rate. The devices consists of a pulse generator (a battery and electronic circuitry) connected to one or two insulated wires (leads). The pulse generator is usually implanted under the collarbone, just beneath the skin. The main lead is inserted into the lower right heart chamber (the right ventricle). A second lead may be placed in the upper right heart chamber (the right atrium).

If you or your loved one is implanted with the Guidant Ventak Implantable Cardioverter Defibrillator that has experienced a short circuit, and you wish to consult with us, please call Gary Wilson at 612-349-8413, or Tara Sutton  at 612-349-8577 (or call 1-800-553-9910).  You can also send them an e-mail by clicking on this link: contact us.

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer

Tara D. Sutton

Partner

Chair, National Mass Tort Group;
Member of Executive Board

Related Publications

September 27, 2022
Briefly: 8th Circuit Introduces Quality Control Aid for Briefs
Eric Magnuson and Sandra Badin - Minnesota Lawyer
September 2022
September 2022
Greenwashing Litigation is Increasing
Gabriel Berg, Waleed Abbasi - The Robins Kaplan Spotlight
September 2022
Legal Strategies For ESG Initiatives
Peter Foundas, Manleen Singh - The Robins Kaplan Spotlight
September 13, 2022
Patent Value: Scoring Patents Using Characteristics Of Patents In Litigation
Christopher K. Larus, Miles A. Finn, Congnan Zhan, Joseph (Yu) Chen, and Shelley Gilliss - les Nouvelles
Back to Top